Automated Manual Lymphatic Drainage Therapy to Improve Glymphatic Function in OSA Patients

Part of paid clinical trials in Rochester, Minnesota.

Sponsor
Mayo Clinic
Study ID
NCT07301762
Status
Enrolling By Invitation

Conditions

  • OSA
  • Obstructive Sleep Apnea
  • Obstructive Sleep Apnea (OSA)

Eligibility Criteria

Sex
ALL
Age
50 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Automated manual lymphatic drainage therapy (AMLDT) device — DEVICE
    The AMLDT device (Neuroglide) is an FDA-cleared Class II medical device (K202693) for over-the-counter use for pain. It mimics manual lymphatic drainage through a pneumatic mat that performs rhythmic inflation and deflation in ascending fashion.

Study Details

The purpose of this research is to investigate whether enhancing systemic lymphatic drainage improves glymphatic function in patients with obstructive sleep apnea (OSA).

Key Dates

Start date
Nov 24, 2025
Status verified
Dec 2025
Primary completion
Jun 30, 2026
Completion
Jun 30, 2026

Study Design

Enrollment
12 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER

Arms

  • Other: Intervention
    Open-Label intervention

Primary Outcome Measure

Difference in serum biomarkers [ Time Frame: Baseline and Day 31 ]

Locations (1)

FacilityCityStateZIPSite coordinators
Mayo ClinicRochesterMinnesota55905-

Find similar trials in Rochester, MN

By research site
Mayo Clinic· Rochester, MN

Related Studies